Send us a text

Discover a smarter way to manage and share market access resources with local affiliates

Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? In this webinar we discussed how a centralised platform can streamline resource sharing, ensure access to nationally-relevant evidence, and put the resources your local affiliates need right at their fingertips. The webinar features a conversation with Tim Styche (Market Access & Health Outcomes Director, Smith+Nephew), who shares how his team has solved this challenge with our Global Value Platform.

Learn more at: https://petauri.com/insights/transforming-global-market-access-smarter-resource-management-with-local-affiliates-a-live-webinar/

To discuss your needs or arrange a full demo of the platform email evidence@petauri.com

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as diverse as the US?

In this Global Whispers episode, Louise Maddison (Senior Consultant – Global Market Access, Petauri Evidence) interviews some of our colleagues from Petauri Advisors who are either former payers, or former industry market access leads in the US. Louise puts your questions to:

- Rory Davies – Vice President of Value and Access, Petauri Advisors, with extensive past experience in Chief Clinical roles at Cigna, Flipt and WellDyne
- Dan Vanderpoel – Executive Vice President, Strategic Payer Marketing; Head, Client Solutions, Petauri and former Manager, Trade Relations at Humana
- Shana Gunderson Hua – Vice President of Value and Access, Petauri Advisors and former Medical Affairs Executive Director at Genentech and former AVP of Pharmaceutical Strategy and Contracting at Cigna and Express Scripts (now Evernorth)

We explore what global market access teams need to know about market access and payer engagement in the US. We explore how and why value messaging, pricing, and launch strategies are developed differently for the US market, compared to other key launch markets, and what this means for global teams preparing for US launch or taking a US-developed proposition internationally.

Learn more at: https://petauri.com/insights/communicating-value-to-us-payers-insights-for-pharma-and-medtech/

This episode was first broadcast live as a webinar in March 2025.

Learn more about Petauri Evidence: https://petauri.com/petauri-evidence/

Learn more about Petauri Advisors: https://petauri.com/petauri-advisors/

Meet the ACE team: https://petauri.com/about-us/ace-team/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

Discover how health economics can support successful Medical Device launch, proposition development, and market access

This episode offers an insightful journey into the world of medical device market access. Specialists from our health economics and market access teams explore the hidden challenges faced by medical devices companies when taking new innovations to healthcare leaders, communicating value and demonstrating evidence, and offer tips on leveraging health economics for a successful launch.

Juliet Wallace (Senior Partnerships Coordinator) delves deep with our expert panel into the pivotal role of health economic evaluation in supporting market access for medical devices. Juliet puts audience questions to Hannah Palin (Director, Local Market Access), Calum Jones (Associate Director, Health Economics), and Evelyne Priestman (Consultant, Health Economics).

See full details at: https://mtechaccess.co.uk/launch-strategies-health-economic-modelling-medical-devices/

This episode was originally broadcast live as webinar in February 2025.

https://petauri.com/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence